Webclat / Healthcare
health.webclat.com

Know which campaigns bring patients, without a privacy lawsuit

Ad platforms want a pixel on every page, including the ones about diagnoses and treatments. Health marketing teams that install it are choosing between attribution and exposure - this is about not having to choose.

Quick answer

You can attribute patient acquisition to specific campaigns without letting ad platforms collect raw visitor data from condition, treatment, or appointment pages - the fix is routing that data through your own server first, so platforms get conversion signal instead of a direct read of the page.

The situation

Your marketing team runs Google and Meta ads to fill appointment slots, and the honest way to know if they're working is to let the ad platform's pixel sit on every page a prospective patient visits - including condition pages, treatment pages, and the appointment form itself.

The pain

That pixel is also the thing hospital pixel litigation gets built on: once it's firing on a page about a specific diagnosis, the platform has a data point tying a visitor to that diagnosis, and neither your compliance team nor your legal team signed off on that exchange.

What we build

We route ad and website data through a server you control before anything reaches the ad platform, stripping page context and identifiers the platform doesn't need to optimize - what's called server-side tracking with a consent layer in front of it.

What you get

  • Attribution data good enough to know which campaigns actually fill appointment slots
  • Ad platforms that still optimize toward conversions, because they receive a signal instead of raw page data
  • A tracking setup your privacy officer can review once, instead of case by case, campaign by campaign
  • Fewer condition-adjacent identifiers leaving your systems in the first place

A realistic example

Illustrative - a cancer center whose paid search team had capped spend on treatment-page campaigns out of caution rather than data might find that removing the exposure, not the budget, was what had been limiting the program the whole time. (Illustrative scenario, not a measured result.)

Common questions

Does this mean we stop running ads on treatment or condition pages?

No. It changes what the ad platform receives from those pages, not whether you can market them. The goal is attribution without a direct data exchange the platform can misuse.

Do we still need a business associate agreement with our ad platform?

Ad platforms generally will not sign BAAs, which is exactly why the data reaching them should not be PHI in the first place - server-side routing is how that boundary gets enforced rather than assumed.

Is this the same thing as a consent banner?

No. A consent banner controls when a tag fires. This controls what leaves your systems and how, which matters even after a visitor has consented.

See exactly what your ad campaigns are sending today.

A runtime audit of your public site shows every tag, every pixel, and every third party receiving data from your condition and appointment pages - before you change anything.

Request an audit